FY 2020 Annual Performance Plan and Report - Goal 4 Objective 4
Fiscal Year 2020
Released March, 2019
Topics on this page: Goal 4. Objective 4 | Objective 4.4 Table of Related Performance Measures
Goal 4. Objective 4: Leverage translational research, dissemination and implementation science, and evaluation investments to support adoption of evidence-informed practices
Translational research, dissemination, and implementation science help increase understanding about how best to support knowledge, adoption, and faithful implementation of best practices in the community. Selecting and adopting evidence-based approaches to tackle health, public health, and human services challenges can be a complex undertaking. HHS programs balance requirements to implement high-quality programs with fidelity, while acknowledging the unique needs of specific individuals or target populations, recognizing differences in program and community settings and resources, and respecting linguistic or cultural differences. Understanding threats to successful implementation of a promising practice can help the Department prevent and mitigate those risks early.
The Office of the Secretary leads this objective. The following divisions are responsible for implementing programs under this strategic objective: ACF, ACL, AHRQ, CDC, FDA, HRSA, NIH, OASH, and SAMHSA.
Objective 4.4 Table of Related Performance Measures
Increase the percentage of Community-Based Child Abuse Prevention (CBCAP) total funding that supports evidence-based and evidence-informed child abuse prevention programs and practices (Lead Agency - ACF; Measure ID - 7D)
| FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | |
|---|---|---|---|---|---|---|---|---|
| Target | 76.7 % | 71.4 % | 64.1 % | 62.4 % | 57.3% | 56.4% | Prior Result +3PP | Prior Result +3PP |
| Result | 68.4 % | 61.1 % | 59.4 % | 53.4% | 53.4% | 10/31/19 | 10/31/20 | 10/30/21 |
| Status | Target Not Met | Target Not Met | Target Not Met | Target Not Met | Target Not Met | Pending | Pending | Pending |
Currently, the Children's Bureau and its National Center for CBCAP are working closely with the states to promote more rigorous evaluations of their funded programs. The Children's Bureau defines evidence-based and evidence-informed programs and practices along a continuum, which includes the following four categories of programs or practices: Emerging and Evidence Informed; Promising; Supported; and Well-Supported.
Although this measure shows a downward trend, ACF anticipates a year-over-year increase of 3 percent through FY 2020. In FY 2019 and 2020, ACF is committed to continuing to work with CBCAP grantees to invest in known evidence-based practices, while continuing to promote evaluation and innovation, so as to expand the availability of evidence-informed and evidence-based practice over time. In addition, ACF continues to focus one-on-one and peer learning technical assistance on increased accuracy of data reporting for this measure.
By 2020, develop and test the effectiveness of two strategies for translating cancer knowledge, clinical interventions, or behavioral interventions to underserved communities in community-based clinical settings (Lead Agency - NIH; Measure ID - SRO-5.1)
| Fiscal Year | Target | Result | Status |
|---|---|---|---|
| FY 2013 | N/A | N/A | N/A |
| FY 2014 | N/A | N/A | N/A |
| FY 2015 | N/A | N/A | N/A |
| FY 2016 | N/A | N/A | N/A |
| FY 2017 | Develop 2 strategies for translating validated basic knowledge, clinical interventions, or behavioral interventions to diverse communities and clinical practice through establishing the Partnerships to Advance Cancer Health Equity (PACHE) program between Minority Serving Institutions (MSI) and NCI-designated Cancer Centers (CC). | Several U54 PACHE Partnerships have developed and/or validated evidence-based interventions and tools to help reduce the burden of cancer disparities in underserved communities across the United States. They are working with various community-based organizations (including faith-based organizations and community-based clinical practices and organizations) to disseminate/translate the interventions and tools in the diverse communities. | Target Met |
| FY 2018 | Develop and support 2 partnerships to test validated basic cancer knowledge, clinical or behavioral interventions to diverse communities in clinical practice. | The U54 PACHE Partnerships, through 2 new efforts, developed and/or validated evidence-based interventions and tools to help reduce the burden of cancer disparities in underserved communities across the United States. These partnerships continued to work with various community-based organizations (including faith-based organizations and community-based clinical practices and organizations) to disseminate/translate the interventions and tools for use in diverse communities. | Target Met |
| FY 2019 | Finalize testing and validating the strategies to translate basic cancer knowledge, clinical or behavioral interventions to underserved communities and into clinical practice. | 12/31/19 | In Progress |
| FY 2020 | Finalize testing and validating the strategies to translate basic cancer knowledge, clinical or behavioral interventions to underserved communities and into clinical practice. | 12/31/20 | In Progress |
NIH’s Partnerships to Advance Cancer Health Equity (PACHE) is a program that enables institutions serving underserved health disparity populations and underrepresented students and National Cancer Institute-designated Cancer Centers to train scientists from diverse backgrounds in cancer research and to effectively deliver cancer advances to underserved communities. In FY 2018, PACHE partnerships have developed and/or validated evidence-based interventions and tools to help reduce the burden of cancer disparities in underserved communities across the United States. These partnerships continue to work with various community-based organizations, which include faith-based organizations and community-based clinical practices and organizations, to disseminate and/or translate the interventions and tools for use in diverse communities. The work of these partnerships resulted in raised awareness about cancer and cancer prevention topics of regional relevance, which include cervical cancer, HPV vaccines in the pediatric setting, and betel nut chewing in these multiethnic communities.
In FY 2019 and 2020, NIH will continue to support projects to develop and test dissemination strategies that will shed light on how new interventions can be effectively adopted by communities and clinicians serving various populations with various cancer types.
